Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)

Murray, ML; Meadows, J; Doré, CJ; Copas, AJ; Haddow, LJ; Lacey, C; Jit, M; ... Gilson, R; + view all Murray, ML; Meadows, J; Doré, CJ; Copas, AJ; Haddow, LJ; Lacey, C; Jit, M; Soldan, K; Bennett, K; Tetlow, M; Nathan, M; Gilson, R; - view fewer (2018) Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial). BMC Medical Research Methodology , 18 (1) , Article 125. 10.1186/s12874-018-0581-z . Green open access

https://ift.tt/2Fxrlrn